Crizanlizumab
Definition: Crizanlizumab, sold under the brand name Adakveo among others, is a monoclonal antibody medication that binds to P-selectin. It is a medication used to reduce the frequency of vaso-occlusive crisis in people aged 16 years and older who have sickle cell anemia. It is given by injection into a vein. source: Wikipedia
- ID
- 830160007
- ID date
- 7 Jan 2022
- Previous ID
- 38904111000001109
- Name
- Crizanlizumab